Dr. Aparna Kalyan
Claim this profileNorthwestern University
Expert in Cancer
Studies Bile Duct Cancer
20 reported clinical trials
39 drugs studied
About Aparna Kalyan
Education:
- Earned an MD from Flinders University of South Australia in 2005.
- Completed Residency at The MetroHealth System/Case Western Reserve University in 2011.
- Completed Fellowships at UPMC Medical Education (2014) and McGaw Medical Center of Northwestern University (2015).
Experience:
- Associate Professor at the Feinberg School of Medicine, Northwestern University.
- Focuses on treating a variety of cancers, including anal, colon, esophageal, gastrointestinal, liver, pancreatic, rectal, small bowel, and stomach cancers.
- Board-certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
BRCA1 negative
2Bile Duct Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Aparna Kalyan is currently running
Therasphere + Systemic Therapy
for Liver Cancer
The purpose of this research is to compare progression free survival between two available systemic therapies - immunotherapy and tyrosine kinase inhibitors - after Therasphere® (yttrium-90) treatment in adult patients with advanced hepatocellular carcinoma. The immunotherapy consists of a standard-of-care treatment with Atezolizumab and Bevacizumab. Treatment with tyrosine kinase inhibitors consists of standard-of-care Lenvatinib or Cabozantinib.
Recruiting1 award Phase 2
Chemotherapy vs Chemoradiotherapy
for Rectal Cancer
This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not given, is quality of life better?
Recruiting2 awards Phase 3
More about Aparna Kalyan
Clinical Trial Related1 year of experience running clinical trials · Led 20 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Aparna Kalyan has experience with
- Nivolumab
- Cabozantinib
- Ipilimumab
- Nab-paclitaxel
- Gemcitabine Hydrochloride
- Olaparib
Breakdown of trials Aparna Kalyan has run
Cancer
Bile Duct Cancer
Gallbladder Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aparna Kalyan specialize in?
Aparna Kalyan focuses on Cancer and Bile Duct Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Aparna Kalyan currently recruiting for clinical trials?
Yes, Aparna Kalyan is currently recruiting for 10 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Aparna Kalyan has studied deeply?
Yes, Aparna Kalyan has studied treatments such as Nivolumab, Cabozantinib, Ipilimumab.
What is the best way to schedule an appointment with Aparna Kalyan?
Apply for one of the trials that Aparna Kalyan is conducting.
What is the office address of Aparna Kalyan?
The office of Aparna Kalyan is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.